The Power of Antibodies: Advancing Biomarker-Based Disease Detection and Surveillance
Woei Kean Ng,
No information about this author
Gunasegran Thanusha,
No information about this author
Pei Pei Chong
No information about this author
et al.
Immunological Investigations,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 25
Published: April 21, 2025
Antibodies
have
long
served
as
fundamental
tools
in
disease
diagnosis
and
surveillance.
Their
utility
biomarkers
has
expanded
beyond
infectious
diseases
to
encompass
a
wide
range
of
health
conditions.
This
review
aims
explore
recent
advancements
antibody
biomarker
discovery
their
applications
diagnosing
monitoring
diverse
It
also
examines
the
role
surveillance
public
epidemiological
studies.
A
comprehensive
analysis
literature
was
conducted,
focusing
on
studies
that
identify
characterize
disease-specific
antibodies.
Particular
attention
given
relevance
autoimmune
diseases,
infections,
cancers,
neurological
disorders.
The
highlights
clinical
significance.
discusses
challenges
antibody-based
assessing
prevalence,
tracking
immunity
trends,
supporting
One
Health
strategies.
Recent
demonstrate
significant
potential
improving
early
diagnosis,
personalized
treatment,
population-level
management.
Antibody
continues
play
pivotal
guiding
responses
understanding
dynamics.
Language: Английский
Expression of minichromosome maintenance proteins in the exfoliated cells supplement sputum cytology in the diagnosis of lung cancer
Neeraja Panakkal,
No information about this author
Asha Lekshmi,
No information about this author
K. M. Jagathnath Krishna
No information about this author
et al.
CytoJournal,
Journal Year:
2024,
Volume and Issue:
21, P. 81 - 81
Published: Dec. 31, 2024
Objective:
Sputum
cytology
is
recognized
as
a
straightforward
and
noninvasive
way
to
diagnose
lung
cancer,
although
its
clinical
utility
has
not
yet
been
investigated.
The
objective
of
the
study
was
detect
classify
cancerous
cells
in
sputum
by
examining
their
expression
minichromosome
maintenance
proteins
(MCM2
MCM7).
In
addition,
attempted
evaluate
these
proteins’
potential
biomarkers
cancer
lesions
relationships
with
clinicopathological
characteristics.
Material
Methods:
MCM2
MCM7
samples
evaluated
using
immunocytochemistry
cell
blocks
(
n
=
97),
correlation
features
examined.
Diagnostic
performance
function
sensitivity
specificity.
Results:
Immunoexpression
confined
nuclei
malignant
alone,
suggesting
differential
diagnostic
marker.
They
showed
significant
correlations
tumor
P
<
0.001),
while
alone
exhibited
stage
0.014).
overexpression
markers
notably
pronounced
adenocarcinoma
compared
other
subtypes.
terms
characterizing
cells,
protein
demonstrated
highest
at
92%
an
area
under
curve
(AUC)
0.961,
whereas
had
80%
AUC
0.901.
Conclusion:
This
presents
inaugural
use
on
exfoliated
samples,
proposing
that
analyzing
immunocytochemical
could
serve
cost-effective
approach
for
diagnosing
cancer.
Integrating
assessed
into
routine
cytopathology
laboratories
augment
traditional
morphological
evaluations,
thereby
improving
cytology.
Language: Английский